ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 33 filers reported holding ANTHERA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $401,000 | +2764.3% | 947,187 | +4020.9% | 0.00% | – |
| Q4 2016 | $14,000 | -30.0% | 22,985 | +231.4% | 0.00% | – |
| Q3 2016 | $20,000 | -45.9% | 6,935 | -43.2% | 0.00% | – |
| Q2 2016 | $37,000 | +27.6% | 12,218 | +50.9% | 0.00% | – |
| Q1 2016 | $29,000 | -47.3% | 8,098 | -32.5% | 0.00% | – |
| Q4 2015 | $55,000 | -92.0% | 12,005 | -89.4% | 0.00% | -100.0% |
| Q3 2015 | $689,000 | +29.5% | 113,390 | +83.4% | 0.00% | – |
| Q2 2015 | $532,000 | -33.2% | 61,836 | -65.3% | 0.00% | – |
| Q1 2015 | $796,000 | +148.0% | 178,376 | -12.2% | 0.00% | – |
| Q4 2014 | $321,000 | -6.1% | 203,276 | +14.0% | 0.00% | – |
| Q3 2014 | $342,000 | -34.1% | 178,277 | +16.3% | 0.00% | – |
| Q2 2014 | $519,000 | -1.7% | 153,277 | -2.8% | 0.00% | – |
| Q1 2014 | $528,000 | -8.0% | 157,648 | -15.8% | 0.00% | – |
| Q4 2013 | $574,000 | -37.1% | 187,253 | -17.7% | 0.00% | -100.0% |
| Q3 2013 | $913,000 | – | 227,388 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,900,000 | $16,378,000 | 3.36% |
| Hilltop Park Associates LLC | 120,000 | $1,034,000 | 2.05% |
| Abingworth LLP | 437,994 | $3,767,000 | 1.71% |
| Sio Capital Management, LLC | 238,158 | $2,053,000 | 1.01% |
| Rhenman & Partners Asset Management AB | 619,600 | $5,341,000 | 0.64% |
| Broadfin Capital, LLC | 1,370,457 | $11,813,000 | 0.64% |
| Perceptive Advisors | 1,202,156 | $10,363,000 | 0.62% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 931,257 | $8,027,000 | 0.60% |
| WEXFORD CAPITAL LP | 177,500 | $1,530,000 | 0.41% |
| Rock Springs Capital Management LP | 470,000 | $4,051,000 | 0.30% |